Czasopismo Współczesna Onkologia 2023

Clinical research

High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial

Rafal Dziadziuszko, Nir Peled, Tony Mok, Solange Peters, Santiago Ponce Aix, Jorge Alatorre-Alexander, Brian D. Vicuna, Margaret Maclennan, Vijay Bhagawati-Prasad, Sarah M. Shagan, Erica Schleifman, Thorsten Ruf, Michael S. Mathisen, Shirish M. Gadgeel

Contemp Oncol (Pozn) 2023; 27 (4): 217–223

DOI: https://doi.org/10.5114/wo.2023.135246

Abstract View text (PDF)

Original paper

First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure

Bożena Sikora-Kupis, Piotr Domański, Weronika Fortuniak, Barbara Kruczyk, Szymon Staneta, Mateusz Piętak, Anna Mydlak, Tomasz Demkow, Paulina Dumnicka, Jakub Kucharz

Contemp Oncol (Pozn) 2023; 27 (4): 224–229

DOI: https://doi.org/10.5114/wo.2023.134751

Abstract View text (PDF)

Original paper

Brain tumour detection from magnetic resonance imaging using convolutional neural networks

Irene Rethemiotaki

Contemp Oncol (Pozn) 2023; 27 (4): 230–241

DOI: https://doi.org/10.5114/wo.2023.135320

Abstract View text (PDF)

Original paper

Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study

Piotr Domański, Jadwiga Jarosińska, Barbara Kruczyk, Mateusz Piętak, Anna Mydlak, Tomasz Demkow, Łukasz Kuncman, Marta Darewicz, Bożena Sikora-Kupis, Wojciech Michalski, Jakub Kucharz

Contemp Oncol (Pozn) 2023; 27 (4): 242–248

DOI: https://doi.org/10.5114/wo.2023.134786

Abstract View text (PDF)

Original paper

Characteristics and treatment results of refractory and relapsed acute myeloid leukaemia in paediatric patients treated in Polish Paediatric Leukaemia/Lymphoma Study Group institutions according to the Protocol Acute Myeloid Leukaemia Berlin-Frankfurt-Munster 2012 and a review of novel treatment possibilities in paediatric acute myeloid leukaemia

Magdalena Samborska, Jolanta Skalska-Sadowska, Robert Achkar, Jacek Wachowiak, Katarzyna Derwich, Małgorzata Czogała, Walentyna Balwierz, Szymon Skoczeń, Grzegorz Dobaczewski, Alicja Chybicka, Krzysztof Kałwak, Maryna Krawczuk-Rybak, Katarzyna Muszyńska-Rosłan, Elżbieta Adamkiewicz-Drożyńska, Lucyna Maciejka-Kapuscińska, Ninela Irga-Jaworska, Joanna Pohorecka, Agnieszka Chodała-Grzywacz, Grażyna Karolczyk, Beata Wójcik, Jerzy R. Kowalczyk, Katarzyna Drabko, Joanna Zawitkowska, Katarzyna Mycko, Wanda Badowska, Tomasz Ociepa, Tomasz Urasiński, Barbara Sikorska-Fic, Michał Matysiak, Paweł Laguna, Anna Dąbrowska-Pawliszyn, Renata Tomaszewska, Tomasz Szczepański, Grażyna Sobol, Agnieszka Mizia-Malarz, Małgorzata Ciebiera, Radosław Chaber, Sylwia Kołtan, Mariusz Wysocki, Jan Styczyński, Mariola Woszczyk, Maria Wieczorek, Irena Karpińska-Derda, Justyna Urbańska-Rakus, Katarzyna Bobeff, Joanna Trelińska, Wojciech Młynarski

Contemp Oncol (Pozn) 2023; 27 (4): 249–254

DOI: https://doi.org/10.5114/wo.2023.135327

Abstract View text (PDF)

Original paper

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 transfection of guide RNA targeting on MMP9 as anti-cancer therapy in human cutaneous squamous cell carcinoma cell line A431

Seoh Wei Teh, Abozer Elderdery, Sanjiv Rampal, Suresh Kumar Subbiah, Pooi Ling Mok

Contemp Oncol (Pozn) 2023; 27 (4): 255–262

DOI: https://doi.org/10.5114/wo.2023.135364

Abstract View text (PDF)

Original paper

Lower fluorodeoxyglucose positron emission tomography maximum standardized uptake value may show a better response to stereotactic body radiotherapy of adrenals in oligometastatic disease

Kiril Zhelev, Maria Mihaylova-Hristov, Nikolay Conev, Manoela Cholakova, Bilyana Korabova, Ivaylo Petrov, Nedyalka Georgieva, Nikolay Nedev, Iglika Mihaylova, Mila Petrova, Zahari Zahariev, Ivan Donev

Contemp Oncol (Pozn) 2023; 27 (4): 263–268

DOI: https://doi.org/10.5114/wo.2023.135288

Abstract View text (PDF)

Original paper

Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing

Monika Adamska, Ewelina Kowal-Wiśniewska, Joanna Czerwińska-Rybak, Katarzyna Kiwerska, Marta Barańska, Weronika Gronowska, Jagoda Loba, Katarzyna Brzeźniakiewicz-Janus, Ewa Wasilewska, Aleksandra Łanocha, Małgorzata Jarmuż-Szymczak, Lidia Gil

Contemp Oncol (Pozn) 2023; 27 (4): 269–276

DOI: https://doi.org/10.5114/wo.2023.135365

Abstract View text (PDF)

Original paper

Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia and the occurrence of depressive symptoms

Katarzyna Gibek

Contemp Oncol (Pozn) 2023; 27 (4): 277–283

DOI: https://doi.org/10.5114/wo.2023.135362

Abstract View text (PDF)

Original paper

Preoperative cell-free DNA concentration in plasma as a diagnostic and prognostic biomarker of clear cell renal cell carcinoma

Tomasz Milecki, Katarzyna Kluzek, Natalia Pstrąg, Andrzej Antczak, Wojciech A. Cieślikowski, Mateusz Wichtowski, Łukasz Kuncman, Zbigniew Kwias, Joanna Wesoły

Contemp Oncol (Pozn) 2023; 27 (4): 284–291

DOI: https://doi.org/10.5114/wo.2023.135366

Abstract View text (PDF)

High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial

First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure

Brain tumour detection from magnetic resonance imaging using convolutional neural networks

Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 transfection of guide RNA targeting on MMP9 as anti-cancer therapy in human cutaneous squamous cell carcinoma cell line A431

Lower fluorodeoxyglucose positron emission tomography maximum standardized uptake value may show a better response to stereotactic body radiotherapy of adrenals in oligometastatic disease

Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing

Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia and the occurrence of depressive symptoms

Preoperative cell-free DNA concentration in plasma as a diagnostic and prognostic biomarker of clear cell renal cell carcinoma

Coverage in

Indexed in

Integrated with

Editorial Policies